default author photo

Shenghui Tang

U.S. Food and Drug Administration - Office of Biostatistics

Silver Spring, MD

United States

SCHOLARLY PAPERS

1

DOWNLOADS

69

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Overall Survival in Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer Treated with a CDK 4/6 Inhibitor Plus Fulvestrant: A U.S. Food and Drug Administration Pooled Analysis

Number of pages: 20 Posted: 23 Jun 2021
Government of the United States of America - Division of Oncology Products, U.S. Food and Drug Administration - Office of Biostatistics, U.S. Food and Drug Administration - Office of Oncologic Diseases, U.S. Food and Drug Administration - Office of Biostatistics, U.S. Food and Drug Administration - Office of Biostatistics, U.S. Food and Drug Administration - Office of Oncologic Diseases, U.S. Food and Drug Administration - Office of Oncologic Diseases, U.S. Food and Drug Administration - Office of Oncologic Diseases, U.S. Food and Drug Administration - Office of Oncologic Diseases, U.S. Food and Drug Administration - Office of Oncologic Diseases, U.S. Food and Drug Administration - Oncology Center of Excellence, U.S. Food and Drug Administration - Oncology Center of Excellence, U.S. Food and Drug Administration - Oncology Center of Excellence and Government of the United States of America - Office of Hematology and Oncology Products
Downloads 69 (883,195)

Abstract:

Loading...